Related Experiment Videos
[Changes in the liver in glutenic enteropathy]
Terapevticheskii Arkhiv
|April 11, 2003
Summary
Glutenic enteropathy (GEP) frequently causes liver issues, including biochemical and morphological changes. Early intervention with a gluten-free diet and liver support is crucial for managing these complications.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Context:
- Glutenic enteropathy (GEP), also known as celiac disease, is an autoimmune disorder triggered by gluten ingestion.
- Liver involvement is a recognized, yet often overlooked, complication of GEP.
- Understanding the spectrum of liver manifestations in GEP is essential for comprehensive patient management.
Purpose:
- To investigate the prevalence of clinical, biochemical, and morphological liver abnormalities in patients with GEP.
- To explore the relationship between liver alterations, GEP duration, and the severity of malabsorption syndrome (MAS).
Summary:
- 116 GEP patients underwent clinical, laboratory, and imaging assessments, including liver biopsies.
- Clinical signs of liver affection were observed in 7.2% of patients.
- Hyperaminotransferasemia was noted in 48.4% of new GEP cases and 18.1% on a gluten-free diet, correlating with MAS severity.
- Morphological liver changes included fatty dystrophy, hepatitis, steatohepatitis, and fibrosis.
- Early, adequate therapy for GEP, including a strict gluten-free diet and metabolic correction, showed the most effectiveness in addressing liver complications.
Impact:
- Highlights the significant association between GEP and liver pathology.
- Emphasizes the need for routine liver function monitoring in GEP patients.
- Suggests that prompt and comprehensive treatment of GEP can mitigate liver damage and improve outcomes.